Caution warranted for low-dose radiation therapy for Covid-19.
Indra J DasJohn A KalapurakalBharat B MittalPublished in: The British journal of radiology (2020)
Covid-19 is a morbid respiratory disease that has caused desperate times on a global scale due to the lack of any effective medical treatment. Some in the radiation community are actively proposing low-dose radiation therapy (LDRT) for managing the viral pneumonia associated with Covid-19. This commentary provides a rationale for exercising caution against such a decision as the efficacy of LDRT for viral diseases is unknown, while its long-term adverse risks are well known.
Keyphrases
- sars cov
- low dose
- coronavirus disease
- radiation therapy
- respiratory syndrome coronavirus
- healthcare
- high dose
- mental health
- clinical trial
- squamous cell carcinoma
- intensive care unit
- radiation induced
- risk assessment
- human health
- climate change
- decision making
- acute respiratory distress syndrome
- electronic health record
- respiratory failure
- smoking cessation
- replacement therapy
- drug induced